Please login to the form below

Not currently logged in
Email:
Password:

Obituary: Graeme Chrystal

Zaicom's founding partner and CEO passes away

Graeme ChrystalZaicom International CEO Graeme Chrystal, who has died aged 54, was a true entrepreneur and strategist with an immense capability to quickly understand complex information and develop effective and insightful solutions.

He had worked in the pharmaceutical industry all his professional career, starting in field sales before moving agency-side in 1989 to join Dragon Communications.

After stints at Oxford Clinical Communications and the Medicus unit FSP (Franklin Scientific Projects) Chrystal jointly founded Phase II International Communications and then Zaicom. 

A keen tennis player and skier, who enjoyed his wine and cheese, he was a big man with a big heart who always believed in his people and what they could achieve for themselves.

In addition to maintaining and growing this business Chrystal had in recent years became a mentor to several firms and taken up the post of chairman at Qualifa.

Chrystal passed away suddenly at his new home in Auckland, New Zealand, having emigrated there from the UK in late 2013, and he leaves a wife and two children.

His funeral was held in April 2014 in Auckland and a memorial service is planned for July 2014 in the UK, details of which are available from Louise Sharp (louise@makarahealth.com).

4th June 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics